Why the study?
Timely revascularization is essential to reduce mortality in STEMI but is seldom achieved in China due to patient and medical system-level barriers, necessitating regionally coordinated networks.
Does a regional network and public education intervention improve reperfusion rate in acute STEMI patients?
Does a regional network and public education intervention improve reperfusion rate in acute STEMI patients?
The GAMI study protocol outlines a cluster-randomized trial to evaluate whether a regional network and public education can improve timely reperfusion for STEMI patients in China.
Answers are grounded in this paper and cite their sources.
Tests regional network plus education for timely STEMI reperfusion in China; extends systems interventions to Asian settings.
BackgroundTimely revascularization is essential for ST-segment elevation myocardial infarction (STEMI) patients to reduced mortality rate. However, it's seldom achieved due to patient and medical system-level barriers in China, especially in the rural area. It's needed to establish a regionally coordinated network to promote the early revascularization rate for STEMI patients.MethodsRegional network for Acute Myocardial Infarction (GAMI) is a multi-center, prospective, intervention study with regional intervention. It was carried out in 8 centers by 1:1 cluster randomization in south China with diverse economic and medical levels since 2016. The regional intervention were carried out in the intervention centers, which consisted of intensive public education and regional network construction for STEMI treatment, including community and online propaganda to raised patients' awareness of the treatment for STEMI and establishment of regional clinic-EMS-PCI transfer network for timely primary revascularization. Consecutive acute STEMI patients were enrolled for assessment of regional intervention according to the key performance indicators. The primary study endpoint was reperfusion rate, and secondary endpoints included change of pre-hospital delay, changes of in-hospital delay time and in-hospital outcomes. All patients were followed up for more than 1 year.DiscussionThe GAMI study is a prospective cluster-randomized intervention study, which would provide helpful evaluation of the effectiveness of enhanced public education and regional network construction on regional STEMI treatment Trial registration: Clinical Trials, NCT03928119. Registered , 25 April, 2019, https://clinicaltrials.gov/ct2/show/NCT03928119?id=NCT03928119&draw=2&rank=1
No takes yet. Share an insight, caveat, or question.
He et al. (2021) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: